Suppr超能文献

一个涉及U-47700、地西泮和氟溴西泮的案例研究——高分辨率质谱数据回顾性分析的应用

A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data.

作者信息

Partridge Emma, Trobbiani Stephen, Stockham Peter, Charlwood Cheryl, Kostakis Chris

机构信息

Forensic Science SA (Toxicology), Adelaide, South Australia, Australia.

Flinders University of South Australia, College of Science and Engineering, Sturt Road, Bedford Park, South Australia, Australia.

出版信息

J Anal Toxicol. 2018 Nov 1;42(9):655-660. doi: 10.1093/jat/bky039.

Abstract

The number of new psychoactive substances (NPS) available is constantly increasing, making it difficult for toxicology laboratories to keep screening methods up to date. Full scan high-resolution mass spectrometry (HRMS) is a versatile technique which allows for progressive updating of spectral databases to increase the scope of screening. It also allows for retrospective screening of data-specifically, reprocessing of data files using an updated spectral database without the need for re-extraction or reanalysis.The coronial case reported here illustrates the application of retrospective processing of HRMS data in the detection of emerging NPS. A 28-year-old male with a history of illicit drug use was found deceased at home. Initial routine screening of the post-mortem peripheral blood identified only methylamphetamine, amphetamine and trace amounts of lorazepam. A compound with an accurate mass and isotope ratio consistent with the opioid AH-7921 was also detected in the liquid chromatography (LC)-HRMS screen; however; the retention time and mass spectrum did not match the library. Further investigation confirmed the compound to be U-47700, another opioid and structural isomer of AH-7921. Several months later, after additional NPS had been added to the in-house HRMS database, retrospective screening of the HRMS data was performed, revealing the presence of designer benzodiazepines, diclazepam and flubromazepam as well as the psychedelic drug 2,5-dimethoxy-4-chloroamphetamine (DOC). Quantitative analysis gave the following results in peripheral post-mortem blood: U-47700 (330 μg/L), diclazepam (70 μg/L), flubromazepam (10 μg/L), methylamphetamine (290 μg/L) and amphetamine (150 μg/L) (DOC not quantitated). These substances, along with lorazepam and etizolam, were also confirmed in the post-mortem urine and an investigation into blood and urinary metabolites was carried out. All analyses were performed using the same LC-quadrupole-time of flight method. The cause of death was aspiration (of gastric content into airways and lungs) due to mixed drug toxicity.

摘要

新型精神活性物质(NPS)的种类不断增加,这使得毒理学实验室难以让筛查方法与时俱进。全扫描高分辨率质谱(HRMS)是一项多功能技术,它能逐步更新光谱数据库以扩大筛查范围。它还允许对数据进行回顾性筛查,具体而言,可使用更新后的光谱数据库对数据文件进行重新处理,而无需重新提取或重新分析。此处报告的死因裁判法庭案例说明了HRMS数据回顾性处理在检测新兴NPS中的应用。一名有非法药物使用史的28岁男性被发现死于家中。尸检外周血的初步常规筛查仅发现甲基苯丙胺、苯丙胺和微量劳拉西泮。在液相色谱(LC)-HRMS筛查中还检测到一种精确质量和同位素比与阿片类药物AH-7921一致的化合物;然而,其保留时间和质谱与数据库不匹配。进一步调查证实该化合物为U-47700,它是AH-7921的另一种阿片类结构异构体。几个月后,在内部HRMS数据库中添加了更多NPS后,对HRMS数据进行了回顾性筛查,发现了新型苯二氮䓬类药物、地西泮和氟溴西泮以及致幻药物2,5-二甲氧基-4-氯苯丙胺(DOC)。定量分析得出死后外周血中的以下结果:U-47700(330μg/L)、地西泮(70μg/L)、氟溴西泮(10μg/L)、甲基苯丙胺(290μg/L)和苯丙胺(150μg/L)(DOC未定量)。这些物质以及劳拉西泮和依替唑仑也在死后尿液中得到证实,并对血液和尿液代谢物进行了调查。所有分析均使用相同的LC-四极杆-飞行时间方法。死因是混合药物毒性导致的误吸(胃内容物进入气道和肺部)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验